Elucidation of the molecular mechanisms governing cellular growth is central to our understanding of normal development and cancer. The goal of this proposal is to explore the regulation of the principal cell cycle checkpoint, the G1/S transition, in the context of the developing mouse lens. Our main focus will be on the regulation of a G1 cyclin-dependent kinase (cdk), cdk4, and its functional relationship to the retinoblastoma (Rb) protein. The cdk4 complex has captured center stage in the cell cycle field because of its documented importance in the proliferative response of cells to growth factors and of the involvement of its associated proteins in cancer pathogenesis. Activity of the cdk4 complex is regulated in large part through direct interactions with positive (cyclin D) and negative (inhibitors of cdk4, e.g. p15/INK4 and p16INK4) modulatory proteins. Owing to a foundation laid over the past 6 years, my laboratory is now uniquely positioned to address in a comprehensive manner the function of cdk4 and its associated regulatory proteins in normal mammalian development. This opportunity arises from (i) establishment of the lens as an ideal system for examining growth control in vivo (EMBO J, 1995) and demonstration that Rb, the substrate of cdk4, plays a central and essential role in lens cell growth control (Nature, 1994), (ii) characterization of the functional interrelationships among p16INK4, cdk4, Myc and Rb proteins in several cell culture systems (Science, 1995), (iii) generation of 4 different transgenic mouse lines (various cyclin D and cdk4 constructs) and a germline null mutation of the pl6INK4 gene, (iv) availability of cancer-prone transgenic mouse models that we and others have generated, and most importantly, (v) extensive experience in employing the mouse as an experimental system for the analysis of gene function. Characterization of this full complement of gain-of function and loss-of-function mouse models will allow us to understand the function of cyclin D, cdk4, and p15INK4, p16INK4 genes in the regulation of the G1/S transition in normal tissues in vivo and in the genesis of cancer. With respect to the cancer studies, we will examine and compare the onset and distribution of tumors arising in each mouse model separately, in combination with each other, or in conjunction with cancer- prone mice (such as p53-/- or some of our Myc transgenics). Finally, the connection of p16INK4 to familial melanoma will prompt an assessment of whether UV exposure of null p16INK mice accelerates the development of skin cancers.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY011267-05
Application #
2906760
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1996-01-26
Project End
2000-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Artandi, S E; DePinho, R A (2000) A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev 10:39-46
Gomez Lahoz, E; Liegeois, N J; Zhang, P et al. (1999) Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol Cell Biol 19:353-63
Sharpless, N E; DePinho, R A (1999) The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 9:22-30
Chin, L; Pomerantz, J; DePinho, R A (1998) The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci 23:291-6
Radfar, A; Unnikrishnan, I; Lee, H W et al. (1998) p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc Natl Acad Sci U S A 95:13194-9
Holland, E C; Hively, W P; DePinho, R A et al. (1998) A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev 12:3675-85
Zhang, P; Wong, C; DePinho, R A et al. (1998) Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev 12:3162-7